What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: ABS
85%DGNews: Thrombus Precursor Protein (TpP) Diagnostic Test Cleared by FDA
83%DGNews: DG DISPATCH - ACAAI: Acute Bacterial Sinusitis Responds To Short Course Gemifloxacin Therapy
83%DGNews: ABS Issued U.S. Patent for Method of Diagnosing Alzheimer's Disease
82%DGNews: FDA Approves Zithromax (Azithromycin) as Once-Daily, Three-Day Treatment for Acute Bacterial Sinusitis
82%DGNews: FiF Test Found to Predict Prevalence of Cardiovascular Disease
81%DGNews: Glaxosmithkline Receives FDA Approval For Augmentin XR (Amoxicillin/Clavulanate Potassium) Extended Release Tablets
80%DGNews: Heart Attack-Detection Breakthrough Reported
79%DGNews: First Single-Dose Oral Antibiotic Zmax (Azithromycin Extended Release) Available in US Pharmacies for Adults with Certain Types of Sinusitis and Pneumonia
78%DGNews: Five-Day Moxifloxacin Can Provide Benefits for Acute Bacterial Sinusitis: Presented at ACAAI
75%DGNews: New EXPLORER Results Show Patients Achieved Dramatic Reductions in C-Reactive Protein And LDL-C Levels With Rosuvastatin Combination Therapy
75%DGNews: Pfizer's Single-Dose Antibiotic Zmax (Azithromycin Extended Release) Receives FDA Approval
75%DGNews: MASCC: Kytril (Granisetron) More Effective In Controlling Chemotherapy Induced Nausea And Vomiting
74%DGNews: Ketek (telithromycin) No Longer Approved in Canada for Treatment of Bronchitis, Sinusitis or Tonsillitis/Pharyngitis
74%DGNews: Oscient Pharmaceuticals and Pfizer, S.A. de C.V. Announce Launch of Factive(R) (Gemifloxacin Mesylate) Tablets in Mexico
74%DGNews: BTS: Adjustable Dosing Provides Greater Empowerment For Asthmatics
74%DGNews: AAAAI: Moxifloxacin Hastens Symptom Resolution in Acute Sinusitis
74%DGNews: ICAAC: Bacteria More Resistant to Newer Therapy Than to Older Penicillin
74%DGNews: FDA Approves Intravenous Avelox (Moxifloxacin) For Pneumonia, Sinusitis and Other Infections
74%DGNews: Zyprexa (Olanzapine) IntraMuscular Rapidly Controls Acute Agitation in Bipolar Mania
74%DGNews: Schizophrenics Taking Antipsychotic Seroquel (Quetipine) May Experience Fewer Side Effects
72%DGNews: Recommendations Support Key Role of Radioembolization in Treatment of Unresectable Liver Tumors
71%DGNews: Crestor (Rosuvastatin) May Be Associated With Arrested Progression of Atherosclerosis and Regression of Plaques at Sites With The Most Disease
70%DGNews: Sanofi-Aventis Announces Update to Ketek (Telithromycin) U.S. Prescribing Information
70%DGNews: FDA Approves of Avelox (Moxifloxacin HCl) for Treatment of Complicated Skin and Skin Structure Infections
70%DGNews: SABCS: New Data For Faslodex (Fulvestrant) Demonstrate Efficacy Following Aromatase Inhibitor Therapy
70%DGNews: Seroquel (Quetiapine Fumarate) May Be Effective In Treating Rapid-Cycling Bipolar Disorder
70%DGNews: RSM: Missed Treatment Opportunities Compromise Survival Rates for British Cancer Patients
69%DGNews: FDA Approves New Indication for Avelox (moxifloxacin HCl) for Treatment of Complicated Intra-Abdominal Infections
69%DGNews: AAAAI: Ketek (Telithromycin) Shows Activity in Acute Maxillary Sinusitis Caused By Drug Resistant Bacteria
68%DGNews: Avelox IV (Moxifloxacin) Approved in Europe to Treat Complicated Skin and Skin Structure Infections
67%DGNews: FDA Approves Avelox (Moxifloxacin) for Community Acquired Pneumonia Due to Multi-Drug Resistant Streptococcus pneumoniae
67%DGNews: ICC: Ketek (Telithromycin) Highly Effective In Treatment Of Pneumococcal Bacteraemia Associated With Pneumonia
66%DGNews: New Data Shows Telmisartan (Micardis/Pritor) Provides Effective and Well-Tolerated Blood Pressure Lowering in Chronic Kidney Disease Patients
66%DGNews: ATS: Avelox (moxifloxacin HCl) Appears More Effective Than Commonly Prescribed Antibiotics in Treating Chronic Bronchitis
66%DGNews: ICAAC: Ketek (Telithromycin) Active in Treating Community-acquired Pneumonia Caused by Streptococcus pneumoniae
65%DGNews: Europe Approves New Strengths Of Avandamet (Rosiglitazone Maleate/Metformin) For Treatment Of Type 2 Diabetes
65%DGNews: Europe Issues Positive Opinion on Use of New Strength Avandamet (Rosiglitazone Maleate/Metformin HCl) as Treatment for Type 2 Diabetes
65%DGNews: ISA: Crestor (Rosuvastatin) Slows Progression and Regression of Atherosclerosis
64%DGNews: Astrazeneca Announces Recentin(TM) As Global Trademark For Novel Cancer Treatment, AZD2171
64%DGNews: Moxifloxacin Monotherapy as Effective as High-Dose Levofloxacin and Ceftriaxone Combination Therapy in Treating Patients With Severe Community-Acquired Pneumonia
63%DGNews: Efficacy of Once-Daily Moxifloxacin in Treating Complicated Intra-Abdominal Infections Highlighted in Two Clinical Data Presentations at ICAAC
63%DGNews: New Data Confirm That Using Arimidex (Anastrozole) From the Start Can Help More Women Live Cancer-Free for Longer
63%DGNews: Arimidex (Anastrozole) Shown to be Gold Standard for Advanced Breast Cancer
63%DGNews: ADA: Avandia May Reduce Cardiovascular Risk By Targeting Fundamental Cause Of Type 2 Diabetes
62%DGNews: Avelox as Effective as Multi-Dose Combination Therapy for Intra-Abdominal Infections
62%DGNews: 5-Day Avelox (Moxifloxacin HCl) Provides Clinical Success in Patients With Acute Exacerbations of Chronic Bronchitis
62%DGNews: ICBD: Seroquel (Quetiapine) Effective, Well Tolerated Treatment For Bipolar Disorder
61%DGNews: Europe Approves Avandamet (Rosiglitazone Maleate/Metformin HCl) Treatment for Type 2 Diabetes
61%DGNews: ESFC-BD: Study Examines Seroquel (Quetiapine) in the Treatment of Acute Mania
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.